

IN BRIEF: MaxCyte makes administrative changes ahead of Nasdaq listing


UK shareholder meetings calendar - next 7 days


EXECUTIVE CHANGES: Keywords Studies CEO Day retires after 12 years


TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry


(Sharecast News) - Cell-based therapy developer MaxCyte announced the signing of a strategic platform licence with clinical-stage biotechnology compan...


IN BRIEF: MaxCyte prepares for listing in New York


(Sharecast News) - Cell engineering technology company MaxCyte has submitted a draft registration statement with the Securities and Exchange Commissio...


IN BRIEF: MaxCyte to consolidate two lines of common stock into one